retatrutide dose trial Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity What caught my attention wasn't

Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients

Weight-loss injections arent recommended in these situations, regardless of BMI: If youre under 18 (Mounjaro and Wegovy are licensed for adults) If youre pregnant or breastfeeding If youre currently struggling with, or recovering from, an eating disorder

Shepherd noted that women who take medications for weight loss during menopause should pay special attention to their diet and exercise in order to not exacerbate the loss of muscle mass and bone density already common among menopausal women

Boursi, B., Mamtani, R., Haynes, K